Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trialKazumoto Iijima, Yasuo Ohashi, Koichi Kamei et al.|The Lancet|2014Cited by 450
Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximabKazumoto Iijima, Koichi Kamei, Kenji Ishikura et al.|Pediatric Nephrology|2017Cited by 54
Urinary screening and urinary abnormalities in 3‐year‐old children in JapanTakeshi Yanagihara, Masataka Honda, Shori Takahashi et al.|Pediatrics International|2015Cited by 18